DailyStocks Stock Article Search

https://www.zacks.com/stock/news/2254837/core-main-cnm-sees-a-more-significant-dip-than-broader-market-some-facts-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2254837 Apr 12, 2024 - Core & Main (CNM) concluded the recent trading session at $56.34, signifying a -1.47% move from its prior day's close. 0

https://www.zacks.com/stock/news/2254423/wall-street-analysts-see-byrna-technologies-byrn-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2254423 Apr 12, 2024 - According to the average brokerage recommendation (ABR), one should invest in Byrna Technologies (BYRN). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://www.zacks.com/stock/news/2254428/wall-street-analysts-see-high-tide-hiti-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2254428 Apr 12, 2024 - According to the average brokerage recommendation (ABR), one should invest in High Tide (HITI). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock? 0

https://www.wired.com/story/the-quest-to-save-megalopolis-starts-now/ Apr 12, 2024 - Sci-fi fiends have a long history of saving their darlings. Francis Ford Coppola’s epic Megalopolis, 40 years in the making, could be their biggest save yet. 0

https://seekingalpha.com/news/4089059-fda-chief-sees-no-reason-for-delay-in-cannabis-rescheduling?source=feed_sector_healthcare Apr 11, 2024 - The head of the FDA, Robert Califf, argues that there is no reason for the DEA to delay its decision on rescheduling marijuana. Read more here. 0

https://www.zacks.com/stock/news/2253959/wall-street-analysts-see-a-27-21-upside-in-j-jill-jill-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2253959 Apr 11, 2024 - The consensus price target hints at a 27.2% upside potential for J.Jill (JILL). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://www.zacks.com/stock/news/2253885/wall-street-analysts-see-p-g-pg-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2253885 Apr 11, 2024 - Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.cnbc.com/2024/04/11/chinas-commercial-property-segment-is-seeing-some-bright-spots-.html Apr 10, 2024 - China's commercial property sector is seeing pockets of demand amid an overall real estate slump. 0

https://www.rttnews.com/story.aspx?Id=3438141 Apr 10, 2024 - After moving sharply lower early in the session, stocks continue to see significant weakness in afternoon trading on Wednesday. The major averages have all moved to the downside after closing mixed in each of the two previous sessions. 0

https://www.fool.com/investing/2024/04/10/look-up-and-see-the-future/?source=iedfolrf0000001 Apr 10, 2024 - Sierra Space is trying to build an economy in low Earth orbit (LEO). 0